Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
All this so called new products are not doing anyone any good when this Pig is Dying,or is it dead already...Sorry...
what can we do?? I have cvrs in my portfolio,,again
Are we rich?
Only lawyer can handle this problem.
If any peolple has capability support for a lawsuit, contact me.
why? the company solved the CVR by themselve without result of the
auditor.
Who is the auditor or the trustee for the CVR proceed?
If you can answer to this question you may see the laywer.
GekkoStarr ..... you are right.
in the united states,,,any news on APCVZ??
thanks so much!
to much suspicious trading activity?
Why are we halted?
why are you guys trying to sucker people into throwing away their money on this POS
this stock is trading?
The symbol APCVZ is dead, so why are you guys trying to sucker people into throwing away their money on this POS? If you are stuck with a ton, you still can't sell, because it's not trading anymore.
Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist and Deregister Contingent Value Rights for APP Pharmaceuticals
SCHAUMBURG, Ill., Mar 07, 2011 (BUSINESS WIRE) --
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that on March 4, 2011, it filed a Form 25 with the NASDAQ and the United States Securities and Exchange Commission with respect to its Contingent Value Rights ("CVRs") listed on the NASDAQ Capital Market. As previously disclosed in its 10-K filing on February 23, 2011, the Form 25 will delist the CVRs from the NASDAQ and deregister the CVRs under Section 12(b) of the Securities and Exchange Act of 1934 (the "Exchange Act"). The NASDAQ suspended trading of the CVRs effective the close of trading on March 4, 2011. On or about March 15, 2011, the Company intends to suspend its reporting requirements under the Exchange Act pending deregistration of the CVRs.
Here is the sec filing.
http://phx.corporate-ir.net/phoenix.zhtml?c=130431&p=irol-sec#7446523
Here is some news, you might be waiting for a while.
http://phx.corporate-ir.net/phoenix.zhtml?c=130431&p=irol-newsArticle&ID=1536541&highlight=
i retire in 2033
Patience is the key here
i loaded up on air shares today
Order still not filled! This is looking more and more like April's Fool's to me. Come on board, why are you hiding for me here?
Go APCVZ GO
Product of the decade... and far beyond...
apcvz
APCVZ = top notch management
I like the international expansion, the more eyes are on this gem, the higher the pps, though I still won't wait for the 6$... as said earlier one buck fits...
Go APCVZ Go
no guts no glory
last i heard they are moving over to the
tokyo exchange to get away from the manipulation
I have no guts to bid above the ASK... Don't like the volume at all...
Better wait and see... imo...
apcvz
Yeah, always the same manipulation going on here... Are we pink or?
also - i think the mm's are helping the hedge funds cover their naked shorts- lot's of games in this market- be careful
i have a bid above the ask - must be mm games - they are scared and trying to hold us back-imo
No insiders buying? That's always a guess with rumors... if it was 100% true we should have seen more volume...
GO APCVZ GO
Hmmm that's why every one is waiting, and no one is selling, this rumor must be true imo...
no - i read it on ragingbull.com
Yahoo board rumor?
is the rumor true - big news next week?
Well on Friday most people have already their weekend. Patience is the key here imo...
the way it trades - could be as low as zero
Shares are thin here... wonder how much the float really is.
i understand - stay under the radar and load the boat while no one is looking - smart (or should i say-clever) move.
Honestly I hope we don't make the buzz today, because I still haven't got one share filled the last week. Order Good Till Cancel... maybe I should raise the BID?
do you think we will make the buzz cloud?
Yeah, but I won't wait for six... I will be out at one buck... for sure... too low volume to keep it in my portfolio till 2012...
Well low volume, but if more eyes see this we will see over a buck, some investors were talking about 6 dollars last months...
Go APCVZ Go
is this a good stock?
low volume, but that's just mm's manipulation imo... this will spike again...
Go APCVZ Go
can somebody post an Intra Day Chart please?
I never pumped this turd, I just watched on side lines, was too good to be true !
My only point is, your glee / pleasure that some lost.
Lol,dont forget apcvz to $6.00,tell your friends lol.....deal of the century lol........you are invaluable to ihub :)
This was not common. Actually pretty uncommon. But 0, yes. Nighty night all, been fun (watching).
Your level of glee, is annoying even to people who didn't lose 1C. !
Go away puke. !
APCVZ deleted by DTCC :
http://www.dtcc.com/downloads/legal/imp_notices/2011/nscc/otc/OTC-044.pdf
Followers
|
56
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4963
|
Created
|
08/10/09
|
Type
|
Free
|
Moderators |
APCVZ
About Fresenius Kabi Pharmaceuticals Holding, Inc. / APP Pharmaceuticals, Inc.
Fresenius Kabi Pharmaceuticals Holding, Inc., a wholly owned subsidiary of Fresenius Kabi AG, acquired APP Pharmaceuticals, Inc. on September 10, 2008. APP Pharmaceuticals, Inc. is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. For more information about APP Pharmaceuticals, Inc., please visit the company's Web site at www.APPpharma.com.
http://www.apppharma.com/index.aspx
Employees
As of December 31, 2009, we had a total of 1,615 full-time employees, of which 65 were engaged in research and development, 411 were in quality assurance and quality control, 843 were in manufacturing, 96 were in sales and marketing and 200 were in administration and finance. None of our employees are represented by a labor union or subject to a collective bargaining agreement. We have not experienced any work stoppage and consider our relations with our employees to be good.
NEWS:
10-29-2010 APP Pharma cleared by FDA for hypertension drug
TEL AVIV (MarketWatch) -- APP Pharmaceuticals Inc., the Schaumburg, Ill., drugmaker, was cleared by the U.S. Food and Drug Administration to market chlorothiazide sodium injection to treat high blood pressure as well as fluid retention for patients with congestive heart failure, cirrhosis of the liver and other ailments. The drug is a generic equivalent to Diuril, which is produced by Lundbeck Pharmaceuticals. /quotes/comstock/11i!hluky (HLUK.Y 18.19, +0.04, +0.22%) APP Pharma is a subsidiary of Fresenius Kabi Pharmaceuticals Holding Inc.
3-19-2010 APP Pharmaceuticals is owned by Fresenius and received FDA approval for their injectable intravenous generic indomethacin late Friday
Here is the link to the FDA website: http://www.fda.gov/Drugs/NewsEvents/ucm1...
The CVRs In connection with the Merger, each APP shareholder was issued one contingent value right of FKP Holdings. The CVRs are intended to give holders an opportunity to participate in any excess Adjusted EBITDA, as defined in the CVR Indenture, generated during the three years ending December 31, 2010, referred to as the “CVR measuring period,” in excess of a threshold amount. Each CVR represents the right to receive a pro rata portion of an amount equal to 2.5 times the amount by which cumulative Adjusted EBITDA of APP and FKP Holdings and their subsidiaries on a consolidated basis, exceeds $1.267 billion for the three years ending December 31, 2010. The maximum amount payable under the CVR Indenture is $6.00 per CVR |
February 23, 2011
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) today filed its Form 10-K for APP which provides an update on the Contingent Value Rights (CVRs) granted to APP stockholders in September 2008 in conjunction with Fresenius Kabi Pharmaceuticals Holding's acquisition of APP.
The company will give formal notice to the NASDAQ Capital Market of its intention to deregister under the Securities Exchange Act of 1934 (the "Exchange Act") and delist the CVRs from the NASDAQ. The Company will also terminate its obligation to file periodic reports, such as a Form 10-K, Form 10-Q or Form 8-K, under the Exchange Act. It is expected that the CVRs will cease trading on NASDAQ on March 4, 2011. The delisting is expected to be made effective by the NASDAQ prior to the end of the first quarter 2011
AFTER HOUR TRADES --> www.nasdaq.com/aspxcontent/ExtendedTradingTrades.aspx
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |